STOCK TITAN

[Form 4] Bruker Corporation Insider Trading Activity

Filing Impact
(Neutral)
Filing Sentiment
(Negative)
Form Type
4
Rhea-AI Filing Summary

Herman Gerald N., Executive Vice President and CFO of Bruker Corporation, reported the withholding of vested restricted stock units to satisfy tax obligations. The Form 4 shows three withholding transactions over August 9–11, 2025: 1,846 shares on 08/09 at $30.43, 1,380 shares on 08/10 at $30.43, and 1,420 shares on 08/11 at $30.78. The company’s explanatory note states these shares were withheld to cover taxes arising from vesting of previously granted RSUs.

Following the reported transactions, the filing lists beneficial ownership declining across those dates to 79,539, then 78,159, and finally 76,739 shares held directly by the reporting person. These entries are recorded under Transaction Code F and are presented as direct ownership on the Form 4.

Herman Gerald N., Vicepresidente esecutivo e Direttore finanziario (CFO) di Bruker Corporation, ha comunicato la trattenuta di unità azionarie ristrette maturate per soddisfare obblighi fiscali. Il Modulo 4 riporta tre operazioni di trattenuta tra il 9 e l'11 agosto 2025: 1.846 azioni il 09/08 a $30.43, 1.380 azioni il 10/08 a $30.43 e 1.420 azioni l'11/08 a $30.78. La nota della società spiega che queste azioni sono state trattenute per coprire le imposte derivanti dalla maturazione di RSU precedentemente assegnate.

A seguito delle operazioni segnalate, il documento indica una diminuzione della partecipazione effettiva nelle date indicate a 79.539, poi 78.159 e infine 76.739 azioni detenute direttamente dalla persona che ha presentato la dichiarazione. Le voci sono registrate con il Codice di Transazione F e sono presentate come proprietà diretta nel Modulo 4.

Herman Gerald N., vicepresidente ejecutivo y director financiero (CFO) de Bruker Corporation, informó la retención de unidades de acciones restringidas adquiridas para satisfacer obligaciones fiscales. El Formulario 4 muestra tres operaciones de retención entre el 9 y el 11 de agosto de 2025: 1.846 acciones el 09/08 a $30.43, 1.380 acciones el 10/08 a $30.43 y 1.420 acciones el 11/08 a $30.78. La nota explicativa de la compañía indica que estas acciones se retuvieron para cubrir impuestos generados por la consolidación de RSU previamente otorgadas.

Tras las operaciones informadas, la presentación refleja una disminución de la propiedad beneficiaria en esas fechas a 79.539, luego 78.159 y finalmente 76.739 acciones mantenidas directamente por la persona que informa. Estas anotaciones están registradas bajo el Código de Transacción F y se presentan como propiedad directa en el Formulario 4.

Herman Gerald N., Bruker Corporation의 전무 겸 최고재무책임자(CFO),은(는) 발생한 세금 의무를 충당하기 위해 기취득(vested) 제한부 주식 단위(RSU)를 원천징수했다고 보고했습니다. Form 4에는 2025년 8월 9일~11일에 걸쳐 세 차례의 원천징수 거래가 기록되어 있습니다: 08/09에 1,846주를 $30.43에, 08/10에 1,380주를 $30.43에, 08/11에 1,420주를 $30.78에 원천징수했습니다. 회사의 설명에는 이 주식들이 이전에 부여된 RSU의 베스팅으로 인한 세금을 충당하기 위해 원천징수되었다고 적혀 있습니다.

보고된 거래 이후 제출 문서에는 보고인 직접 보유량이 해당 일자들에 걸쳐 79,539, 이어 78,159, 최종적으로 76,739주로 감소한 것으로 기재되어 있습니다. 이 항목들은 거래 코드 F로 기록되었으며 Form 4에 직접 소유로 표시되어 있습니다.

Herman Gerald N., vice‑président exécutif et directeur financier (CFO) de Bruker Corporation, a déclaré la retenue d'unités d'actions restreintes acquises pour couvrir des obligations fiscales. Le formulaire 4 montre trois opérations de retenue entre le 9 et le 11 août 2025 : 1.846 actions le 09/08 à $30.43, 1.380 actions le 10/08 à $30.43 et 1.420 actions le 11/08 à $30.78. La note explicative de la société indique que ces actions ont été retenues pour couvrir les impôts dus à l'acquisition (vesting) des RSU précédemment attribuées.

À la suite des opérations déclarées, le dépôt indique une baisse de la détention bénéficiaire à ces dates, à 79.539, puis 78.159, et enfin 76.739 actions détenues directement par le déclarant. Ces entrées sont enregistrées sous le code de transaction F et sont présentées comme propriété directe dans le formulaire 4.

Herman Gerald N., Executive Vice President und Chief Financial Officer (CFO) von Bruker Corporation, meldete die Einbehaltung fälliger Restricted Stock Units zur Erfüllung steuerlicher Verpflichtungen. Das Formular 4 weist drei Einbehaltstransaktionen vom 9. bis 11. August 2025 aus: am 09.08. 1.846 Aktien zu $30.43, am 10.08. 1.380 Aktien zu $30.43 und am 11.08. 1.420 Aktien zu $30.78. Die Unternehmensnotiz erklärt, dass diese Aktien einbehalten wurden, um die aufgrund der Vesting von zuvor gewährten RSU anfallenden Steuern zu decken.

Im Anschluss an die gemeldeten Transaktionen verzeichnet die Einreichung einen Rückgang des wirtschaftlichen Eigentums an den genannten Daten auf 79.539, dann 78.159 und schließlich 76.739 Aktien, die vom Meldenden direkt gehalten werden. Die Einträge sind unter dem Transaktionscode F verbucht und im Formular 4 als direkte Beteiligung ausgewiesen.

Positive
  • Transactions are clearly explained as tax withholding related to vested restricted stock units, providing transparency.
  • Reporting person identified with title (Executive Vice President, CFO), clarifying the filer’s role and direct ownership status.
Negative
  • Beneficial ownership decreased across the reported dates from 79,539 to 76,739 shares due to withheld RSU shares.
  • Multiple withholding events occurred over three consecutive days, creating several line items that require reconciliation for tracking ownership changes.

Insights

TL;DR: Routine tax-withholding of vested RSUs by a senior executive; procedural disclosure, not a market sale.

The reported transactions are described explicitly as shares withheld to satisfy tax withholding obligations on vested restricted stock units, which is a common compensation-related event. The three withholdings across consecutive days total the reported amounts on 08/09/2025, 08/10/2025 and 08/11/2025 and are recorded with Transaction Code F. From a governance and disclosure standpoint, the filing meets Section 16 reporting requirements and clarifies that these were not open-market dispositions but administrative withholdings tied to compensation vesting.

TL;DR: Insider filings show routine RSU tax withholding; impact on float and executive ownership is minimal.

The Form 4 details three small withholding events totaling the stated share amounts, with per-share prices shown at $30.43 and $30.78. The filing provides the beneficiary counts after each transaction, ending at 76,739 shares directly owned. For investors, these transactions are administrative and do not indicate active selling intent; they simply document the company withholding shares to cover taxes associated with vested RSUs.

Herman Gerald N., Vicepresidente esecutivo e Direttore finanziario (CFO) di Bruker Corporation, ha comunicato la trattenuta di unità azionarie ristrette maturate per soddisfare obblighi fiscali. Il Modulo 4 riporta tre operazioni di trattenuta tra il 9 e l'11 agosto 2025: 1.846 azioni il 09/08 a $30.43, 1.380 azioni il 10/08 a $30.43 e 1.420 azioni l'11/08 a $30.78. La nota della società spiega che queste azioni sono state trattenute per coprire le imposte derivanti dalla maturazione di RSU precedentemente assegnate.

A seguito delle operazioni segnalate, il documento indica una diminuzione della partecipazione effettiva nelle date indicate a 79.539, poi 78.159 e infine 76.739 azioni detenute direttamente dalla persona che ha presentato la dichiarazione. Le voci sono registrate con il Codice di Transazione F e sono presentate come proprietà diretta nel Modulo 4.

Herman Gerald N., vicepresidente ejecutivo y director financiero (CFO) de Bruker Corporation, informó la retención de unidades de acciones restringidas adquiridas para satisfacer obligaciones fiscales. El Formulario 4 muestra tres operaciones de retención entre el 9 y el 11 de agosto de 2025: 1.846 acciones el 09/08 a $30.43, 1.380 acciones el 10/08 a $30.43 y 1.420 acciones el 11/08 a $30.78. La nota explicativa de la compañía indica que estas acciones se retuvieron para cubrir impuestos generados por la consolidación de RSU previamente otorgadas.

Tras las operaciones informadas, la presentación refleja una disminución de la propiedad beneficiaria en esas fechas a 79.539, luego 78.159 y finalmente 76.739 acciones mantenidas directamente por la persona que informa. Estas anotaciones están registradas bajo el Código de Transacción F y se presentan como propiedad directa en el Formulario 4.

Herman Gerald N., Bruker Corporation의 전무 겸 최고재무책임자(CFO),은(는) 발생한 세금 의무를 충당하기 위해 기취득(vested) 제한부 주식 단위(RSU)를 원천징수했다고 보고했습니다. Form 4에는 2025년 8월 9일~11일에 걸쳐 세 차례의 원천징수 거래가 기록되어 있습니다: 08/09에 1,846주를 $30.43에, 08/10에 1,380주를 $30.43에, 08/11에 1,420주를 $30.78에 원천징수했습니다. 회사의 설명에는 이 주식들이 이전에 부여된 RSU의 베스팅으로 인한 세금을 충당하기 위해 원천징수되었다고 적혀 있습니다.

보고된 거래 이후 제출 문서에는 보고인 직접 보유량이 해당 일자들에 걸쳐 79,539, 이어 78,159, 최종적으로 76,739주로 감소한 것으로 기재되어 있습니다. 이 항목들은 거래 코드 F로 기록되었으며 Form 4에 직접 소유로 표시되어 있습니다.

Herman Gerald N., vice‑président exécutif et directeur financier (CFO) de Bruker Corporation, a déclaré la retenue d'unités d'actions restreintes acquises pour couvrir des obligations fiscales. Le formulaire 4 montre trois opérations de retenue entre le 9 et le 11 août 2025 : 1.846 actions le 09/08 à $30.43, 1.380 actions le 10/08 à $30.43 et 1.420 actions le 11/08 à $30.78. La note explicative de la société indique que ces actions ont été retenues pour couvrir les impôts dus à l'acquisition (vesting) des RSU précédemment attribuées.

À la suite des opérations déclarées, le dépôt indique une baisse de la détention bénéficiaire à ces dates, à 79.539, puis 78.159, et enfin 76.739 actions détenues directement par le déclarant. Ces entrées sont enregistrées sous le code de transaction F et sont présentées comme propriété directe dans le formulaire 4.

Herman Gerald N., Executive Vice President und Chief Financial Officer (CFO) von Bruker Corporation, meldete die Einbehaltung fälliger Restricted Stock Units zur Erfüllung steuerlicher Verpflichtungen. Das Formular 4 weist drei Einbehaltstransaktionen vom 9. bis 11. August 2025 aus: am 09.08. 1.846 Aktien zu $30.43, am 10.08. 1.380 Aktien zu $30.43 und am 11.08. 1.420 Aktien zu $30.78. Die Unternehmensnotiz erklärt, dass diese Aktien einbehalten wurden, um die aufgrund der Vesting von zuvor gewährten RSU anfallenden Steuern zu decken.

Im Anschluss an die gemeldeten Transaktionen verzeichnet die Einreichung einen Rückgang des wirtschaftlichen Eigentums an den genannten Daten auf 79.539, dann 78.159 und schließlich 76.739 Aktien, die vom Meldenden direkt gehalten werden. Die Einträge sind unter dem Transaktionscode F verbucht und im Formular 4 als direkte Beteiligung ausgewiesen.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Herman Gerald N

(Last) (First) (Middle)
C/O BRUKER CORPORATION
40 MANNING ROAD

(Street)
BILLERICA MA 01821-3915

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
BRUKER CORP [ BRKR ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
EXECUTIVE VICE PRESIDENT, CFO
3. Date of Earliest Transaction (Month/Day/Year)
08/09/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 08/09/2025 F 1,846(1) D $30.43 79,539 D
Common Stock 08/10/2025 F 1,380(1) D $30.43 78,159 D
Common Stock 08/11/2025 F 1,420(1) D $30.78 76,739 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the reporting person.
/s/ Michael Simone, Attorney-in-Fact 08/12/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

Who filed the Form 4 for BRKR?

The Form 4 was filed for Herman Gerald N., who is identified as Executive Vice President and CFO of Bruker Corporation.

What transactions are reported on the BRKR Form 4?

Three withholding transactions to satisfy tax obligations on vested RSUs: 1,846 shares (08/09/2025), 1,380 shares (08/10/2025), and 1,420 shares (08/11/2025).

What prices are shown for the withheld shares on the BRKR Form 4?

Per-share amounts shown in the filing are $30.43 for the first two events and $30.78 for the third event.

Did the Form 4 report open-market sales for BRKR?

No. The filing explains the shares were withheld by the company to satisfy tax withholding obligations on vested restricted stock units, not open-market sales.

What was the reporting person’s direct beneficial ownership after the last transaction?

The filing lists direct beneficial ownership of 76,739 shares following the 08/11/2025 transaction.
Bruker Corp

NASDAQ:BRKR

BRKR Rankings

BRKR Latest News

BRKR Latest SEC Filings

BRKR Stock Data

5.24B
103.25M
31.97%
82.57%
6.24%
Medical Devices
Laboratory Analytical Instruments
Link
United States
BILLERICA